TP53 and neoplasm: The downregulation of these lncRNAs correlated with tumor progression owing to the inhibition of their moderation of the mitogen-activated protein kinase (MAPK), tumor protein p53 (p53), and hypoxia-inducible factor 1-alpha (HIF1-α) pathways [15].